Treatment with 17β-estradiol, leptin, IL-6, and TNF-α (ELIT) for obesity-related inflammation also decrease mitochondrial function and increase oxidative stress, aggressiveness, and motility in cell lines with low estrogen receptor beta (ERβ) expression101. This evidence concerns the gene IL6 and Obesity.